We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $63.9B
1-Year Est. Return 45.56%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+15.23%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.31%
AUM
$110B
AUM Growth
+$18.7B
Cap. Flow
+$7.09B
Cap. Flow %
6.45%
Top 10 Hldgs %
8.73%
Holding
3,883
New
532
Increased
1,751
Reduced
1,105
Closed
465

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$618M
2
VALE icon
Vale
VALE
+$332M
3
CELG
Celgene Corp
CELG
+$309M
4
CME icon
CME Group
CME
+$306M
5
AMZN icon
Amazon
AMZN
+$290M

Sector Composition

Rank Sector Weight
1 Healthcare 16.17%
2 Technology 14.41%
3 Consumer Discretionary 10.61%
4 Financials 10.51%
5 Real Estate 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLE icon
3426
Allegion
ALLE
$14.1B
-20,600
Closed -$1.64M
AME icon
3427
Ametek
AME
$59.2B
-71,150
Closed -$4.82M
AMWD
3428
DELISTED
American Woodmark
AMWD
-8,200
Closed -$457K
ANF icon
3429
Abercrombie & Fitch
ANF
$5B
-27,000
Closed -$541K
AOS icon
3430
A.O. Smith
AOS
$8.51B
-262,000
Closed -$11.2M
ASUR icon
3431
Asure Software
ASUR
$240M
-48,300
Closed -$245K
ATEX icon
3432
Anterix
ATEX
$1.72B
-7,200
Closed -$269K
CVSA
3433
Covista Inc
CVSA
$4.34B
-10,000
Closed -$473K
AVT icon
3434
Avnet
AVT
$8.05B
-208,300
Closed -$7.52M
AVXL icon
3435
Anavex Life Sciences
AVXL
$324M
-18,109
Closed -$28K
AVY icon
3436
Avery Dennison
AVY
$13.7B
-162,900
Closed -$14.6M
AX icon
3437
Axos Financial
AX
$5.7B
-185,000
Closed -$4.66M
AXGN icon
3438
Axogen
AXGN
$2.64B
-255,300
Closed -$5.22M
DCH
3439
Dauch Corp
DCH
$1.6B
-269,385
Closed -$2.99M
AXON
3440
Axon Enterprise
AXON
$48.4B
-205,152
Closed -$8.97M
AXSM icon
3441
Axsome Therapeutics
AXSM
$11.3B
-15,110
Closed -$43K
FABC
3442
Fabric.AI Inc
FABC
$18.6M
-13
Closed -$10K
AYTU icon
3443
AYTU BioPharma
AYTU
$25.7M
-476
Closed -$75K
BAH icon
3444
Booz Allen Hamilton
BAH
$9.41B
-51,494
Closed -$2.32M
BALL icon
3445
Ball Corp
BALL
$16.6B
-79,822
Closed -$3.67M
BBAR icon
3446
BBVA Argentina
BBAR
$3.26B
-50,500
Closed -$572K
BDX icon
3447
Becton Dickinson
BDX
$49.6B
-65,859
Closed -$14.5M
BIP icon
3448
Brookfield Infrastructure Partners
BIP
$18.1B
-88,250
Closed -$1.82M
BKE icon
3449
Buckle
BKE
$2.33B
-103,600
Closed -$2M
BKNG icon
3450
Booking.com
BKNG
$159B
-222,300
Closed -$15.3M

Similar funds

Jim Simons's Q1 2019 Portfolio in Review

As of Q1 2019, Jim Simons held 3,883 positions worth $110B, up 20% from $91.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Jim Simons deployed $7.09B of net new capital in Q1 2019, opening 532 new positions and adding to 1,751 existing holdings. Its largest new stake was Amazon: 3,483,100 shares worth $310M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $342M trimmed.

  • Jim Simons's largest Q1 2019 buy was Amazon: 3,483,100 shares worth $310M.
  • Jim Simons added most to Starbucks in Q1 2019, an estimated $618M increase.
  • Jim Simons's biggest Q1 2019 reduction was Meta Platforms (Facebook), cutting an estimated $342M.
  • Jim Simons fully exited Apple in Q1 2019, selling an estimated $435M.
  • Jim Simons's ten largest holdings make up 8.7% of its $110B portfolio in Q1 2019.
  • Jim Simons opened 532 new positions and closed 465 in Q1 2019.
  • Jim Simons's portfolio value rose 20% quarter-over-quarter to $110B.

Based on Renaissance Technologies's 13F filing for Q1 2019, filed 14 May 2019.